# Pharmacokinetics of Topical SB204 in Adolescents With Acne Vulgaris

> **NCT02801903** · PHASE1 · COMPLETED · sponsor: **Novan, Inc.** · enrollment: 18 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** SB204 4%

## Key facts

- **NCT ID:** NCT02801903
- **Lead sponsor:** Novan, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-07
- **Primary completion:** 2016-08
- **Final completion:** 2016-08-25
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2018-10-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02801903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02801903, "Pharmacokinetics of Topical SB204 in Adolescents With Acne Vulgaris". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02801903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*